GlycoVaxyn
Latest round
- Series B
Last raised
- Mar 2009
Total raised
- $31M
Investors
- 3
About GlycoVaxyn
GlycoVaxyn focuses on creating advanced vaccine technologies.00 mn.The company offers a range of innovative vaccine products designed to address specific challenges in infectious diseases. Their core offerings focus on advanced technology solutions that enhance immune responses and improve patient outcomes.The revenue structure of GlycoVaxyn is primarily based on direct sales to healthcare institutions and collaborations with pharmaceutical companies.GlycoVaxyn plans to utilize the resources from its acquisition to enhance its vaccine development pipeline, with a focus on launching new vaccine candidates targeting emerging infectious diseases in the next few years. The company aims to expand its market presence in Asia and North America by 2025, aligning with growing global health demands.
Who invested in GlycoVaxyn
3 investors across 3 rounds
See all investors in GlycoVaxyn
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GlycoVaxyn
Who invested in GlycoVaxyn?
GlycoVaxyn has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GlycoVaxyn raised?
GlycoVaxyn has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did GlycoVaxyn last raise money?
GlycoVaxyn's most recent round on record is a Series B, in Mar 2009.
What does GlycoVaxyn do?
GlycoVaxyn focuses on creating advanced vaccine technologies.
Where is GlycoVaxyn headquartered?
GlycoVaxyn is headquartered in Schlieren, Switzerland.
Which VCs invest in companies like GlycoVaxyn?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at GlycoVaxyn's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like GlycoVaxyn? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.